Close Menu

NEW YORK (GenomeWeb) — Oxford Biodynamics (OBD) said today that it will partake in a new trial that is assessing methods for early-stage prostate cancer detection.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.